During the annual BIO International Convention (taking place June 13-16 in San Diego), the Biotechnology Innovation Organization elected its new round of executive committee directors for the 2022-2023 term. The elections took place on Monday, June 13, during the convention.
Michelle McMurry-Heath, BIO president and CEO, said, “On behalf of our entire BIO organization, I want to congratulate our incoming Board directors and section leaders. “This is a critical time for our industry. Our BIO Board – especially one as diverse and multi-faceted as this one – will help drive policies that keep pace with innovation’s promise to cure disease, nourish society, and protect our planet.”
The newly elected 2022-2023 executive committee directors are:
- Paul Hastings, Nkarta Therapeutics, board chair/health section chair
- Elizabeth Lewis, Takeda Pharmaceuticals, board associate vice chair and secretary
- Bradford Zakes, Ceravast Medical, BIO board treasurer
- Ted Love, Global Blood Therapeutics, health section vice chair
- Sylvia Wulf, AquaBounty Technologies, agriculture and environment section chair
- John Crowley, Amicus Therapeutics, emerging companies section chair
- Jeremy Levin, Ovid Therapeutics, immediate past chair
- Erika Smith, ReNetX BIO, emerging companies section vice chair
- Anna Rath, Vestaron
- Doug Doerfler, MaxCyte
- Stuart Arbuckle, Vertex Pharmaceuticals
- Christi Shaw, Kite, a Gilead company
- Bill Sibold, Genzyme, a Sanofi company
- Fritz Bittenbender, Genentech Roche
- Chris Boerner, Bristol Myers Squibb
- Eric Dube, Travere Therapeutics
- Sue Washer, Applied Genetic Technologies Corporation (AGTC)
- Aamir Malik, Pfizer
- Jannie Oosthuizen, Merck
- Victor Bulto, Novartis Pharmaceuticals
- Bill Newell, Sutro BioPharma
Other directors confirmed as the executive advisory board (EAB) to the executive committee include:
- Ron Cohen, Acorda Therapeutics
- Rachel King, former BIO Board Chair
- John Maraganore, former BIO Board Chair
- Richard Pops, Alkermes
Newly elected to the BIO health section governing board for the 2022-2025 term:
- Jannie Oosthuizen, Merck
Also, individuals newly elected to the BIO emerging companies section governing board for the 2022-2023 term:
- Pablo Cagnoni, Rubius Therapeutics
- Kaye Foster, The Boston Consulting Group
- Mike Huckman, Real Chemistry
- Elizabeth Jeffords, Iolyx Therapeutics
- Sheila Mikhail, Asklepios BioPharmaceutical
Newly Elected to the BIO Agriculture and Environment Section Governing Board (2022-2024 Term):
- Angela Ailloni, Ginkgo Bioworks
- Rocco Morelli, Recombinetics
